Effective treatment methods of chronic suppurative otitis media

Автор: Khaidarov Ilkhomjon Ikromjon, Usmanova Nilufar Abdumanopovna

Журнал: Life Sciences and Agriculture.

Статья в выпуске: 1 (9), 2022 года.

Бесплатный доступ

Chronic suppurative otitis media is persistent inflammation of the middle ear or mastoid cavity. Synonyms include chronic otitis media, chronic mastoiditis, and chronic tympanomastoiditis. Chronic suppurative otitis media is characterized by recurrent or persistent ear discharge (otorrhea) over two to six weeks through a perforation of the tympanic membrane. Chronic suppurative otitis media usually begins as a complication of persistent AOM (acute otitis media - acute stage), with perforation in childhood. Typical findings may also include thickened granular middle ear mucosa and mucosal polyps. Occasionally, chronic suppurative otitis media will be associated with a cholesteatoma within the middle ear. Chronic suppurative otitis media is differentiated from chronic otitis media with effusion, in which there is an intact tympanic membrane with fluid in the middle ear but no active infection. Chronic suppurative otitis media does not include chronic perforations of the eardrum that are dry, or that only occasionally produce discharge, and have no signs of active infection. Thus, we will discuss effective treatment methods in this article.

Еще

Chronic suppurative otitis media, mastoid cavity, otorrhea, perforation, AOM (acute otitis media - acute stage), polyp, cholesteatoma, effusion chronic otitis media, infection, tympanic

Короткий адрес: https://sciup.org/14124728

IDR: 14124728

Список литературы Effective treatment methods of chronic suppurative otitis media

  • Chronic suppurative otitis media. Burden of Illness and Management Options. Child and Adolescent Health and Development Prevention of Blindness and Deafness World Health Organization Geneva, Switzerland.
  • Systemic antibiotics for chronic suppurative otitis media. Lee-Yee ChongKaren HeadKatie E WebsterJessica DawPeter RichmondTom SnellingMahmood F BhuttaAnne GM SchilderMartin J BurtonChristopher G Brennan-Jones. doi: 10.1002/14651858.CD013052.
  • A new dosage regimen for topical application of ciprofloxacin in the management of chronic suppurative otitis media. Aslan A, Altuntas A, Titiz A, Arda HN, Nalca Y. Otolaryngol Head Neck Surg. 1998 Jun; 118(6):883-5.
  • Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations. Ohyama M, Furuta S, Ueno K, Katsuda K, Nobori T, Kiyota R, Miyazaki YArch Otolaryngol Head Neck Surg. 1999 Mar; 125(3):337-40.
  • Nwabuisi C., Ologe F. E. (2002). Pathogenic agents of chronic suppurative otitis media in Ilorin, Nigeria East Afr Med J 79 202–205 10.4314/eamj.v79i4.8879.
  • In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Dohar JE,Kenna MA, Wadowsky RM Am J Otol. 1996 Mar; 17(2):207-9.
  • Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study. Yuen PW, Lau SK, Chau PY, Hui Y, Wong SF, Wong S, Wei WI Am J Otol. 1994 Sep; 15(5):670-3.
  • Per-operative antibiotic/steroid prophylaxis of tympanostomy tube otorrhoea: chemical or mechanical effect? Shinkwin CA, Murty GE, Simo R, Jones NS J Laryngol Otol. 1996 Jun; 110(6):531-3.
  • Use of ototopical antibiotics in treating 3 common ear diseases. Hannley MT, Denneny JC 3rd, Holzer SS Otolaryngol Head Neck Surg. 2000 Jun; 122(6):934-40.
  • Chronic suppurative otitis media. Acuin J. BMJ Clin Evid. 2007 Feb 1; 2007.
  • Evaluation of topical povidone-iodine in chronic suppurative otitis media. Jaya C, Job A, Mathai E, Antonisamy B Arch Otolaryngol Head Neck Surg. 2003 Oct; 129(10):1098-100.
  • Evaluation of topical povidone-iodine in chronic suppurative otitis media. Jaya C, Job A, Mathai E, Antonisamy B Arch Otolaryngol Head Neck Surg. 2003 Oct; 129(10):1098-100.
  • The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media. Choi HG, Park KH, Park SN, Jun BC, Lee DH, Yeo SW. Acta Otolaryngol. 2010; 130(1):42-6.
  • Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Macfadyen CA, Acuin JM, Gamble C Cochrane Database Syst Rev. 2006 Jan 25; (1):CD005608.
  • Topical treatment of chronic suppurative otitis media. Daniel SJ. Curr Infect Dis Rep. 2012 Apr; 14(2):121-7.
  • Microbiology of the chronic suppurative otitis media. Kristo B, Buljan M. Med Glas (Zenica). 2011 Aug; 8(2):284-6.
  • Brook I. (1994). Management of chronic suppurative otitis media: superiority of therapy effective against anaerobic bacteria Pediatr Infect Dis J 13 188–193 10.1097/00006454-199403000-00004.
  • Brook I. (2008). The role of anaerobic bacteria in chronic suppurative otitis media in children: implications for medical therapy Anaerobe 14 297–300 10.1016/j.anaerobe.2008.12.002.
  • Campos M. A., Arias A., Rodriguez C., Dorta A., Betancor L., Lopez-Aguado D., Sierra A. (1995). Etiology and therapy of chronic suppurative otitis J Chemother 7 427–431 10.1179/joc.1995.7.5.427.
  • Chew Y. K., Cheong J. P., Khir A., Brito-Mutunayagam S., Prepageran N. (2012). Complications of chronic suppurative otitis media: a left otogenic brain abscess and a right mastoid fistula Ear Nose Throat J 91 428–430 .
  • Choi H. G., Park K. H., Park S. N., Jun B. C., Lee D. H., Yeo S. W. (2010). The appropriate medical management of methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media Acta Otolaryngol 130 42–46 10.3109/00016480902870522.
  • Clayton M. I., Osborne J. E., Rutherford D., Rivron R. P. (1990). A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhoea Clin Otolaryngol Allied Sci 15 7–10 10.1111/j.1365-2273.1990.tb00425.x.
  • Clerici W. J., DiMartino D. L., Prasad M. R. (1995). Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro Hear Res 84 30–40 10.1016/0378-5955(95)00010-2.
  • Coates H. L., Morris P. S., Leach A. J., Couzos S. (2002). Otitis media in Aboriginal children: tackling a major health problem Med J Aust 177 177–178.
  • Matanda R. N., Muyunga K. C., Sabue M. J., Creten W., Van de Heyning P. (2005). Chronic suppurative otitis media and related complications at the University Clinic of Kinshasa B-ENT 1 57–62.
  • Monasta L., Ronfani L., Marchetti F., Montico M., Vecchi Brumatti L., Bavcar A., Grasso D., Barbiero C., Tamburlini G. (2012). Burden of disease caused by otitis media: systematic review and global estimates PLoS One 7 e36226 10.1371/journal.pone.0036226.
  • Olatoke F., Ologe F. E., Nwawolo C. C., Saka M. J. (2008). The prevalence of hearing loss among schoolchildren with chronic suppurative otitis media in Nigeria, and its effect on academic performance Ear Nose Throat J 87 E19.
  • Leichtle A., Lai Y., Wollenberg B., Wasserman S. I., Ryan A. F. (2011). Innate signaling in otitis media: pathogenesis and recovery Curr Allergy Asthma Rep 11 78–84 10.1007/s11882-010-0158-3.
  • Azizov B. et al. Clinical characteristics of patients with HIV/AIDS //OOO «Maxliyo-shifo» & V. – Т. 46.
  • Azizov B. S., Ismailova G. A. Sensitivity of skin microflora to antibacterial medications administered to patients with different status of HIV //Likars' ka Sprava. – 2010. – №. 5-6. – С. 124-128.
  • Baram N. I. et al. Immunomodulating activity of gossypol derivatives //Chemistry of Natural Compounds. – 1988. – Т. 24. – №. 5. – С. 547-550.
  • Ismailova G. A., Khegai O. A. IMMUNO-ENDOCRINE MECHANISMS OF REPRODUCTIVE FUNCTION DISORDERS IN WOMEN WITH AUTOIMMUNE THYROIDITIS AND APPROACHES TO THE THERAPY //Central Asian Journal of Medicine. – 2020. – Т. 2020. – №. 3. – С. 65-91.
  • Ismailova G. A., Tukhvatullina Z. G., Yuldashev K. A. The use of new agent with immunomodulatory and antiinflammatory activity in the dermatology //Journal of the European Academy of Dermatology and Venereology. – 1995. – №. 5. – С. S160.
  • Khalidova K. H., Ismailova G. A. Pathomorphosis of the classical Caposi's sarcoma: anamnesis, catamnesis, clinics //Likars' ka Sprava. – 2011. – №. 3-4. – С. 87-91.
  • Khalidova K., Ismailova G. TNF-alpha, IL-6 and IL-8 in patients with idiopathic type of Kaposi's sarcoma //JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. – 111 RIVER ST, HOBOKEN 07030-5774, NJ USA : WILEY, 2019. – Т. 33. – С. 63-63.
Еще
Статья научная